MIR3914-1

Across TCGA pan-cancer cohorts, MIR3914-1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR3914-1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR3914-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3914-1 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, COAD, and LAML are the cancer types where MIR3914-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.074	0.720	<.001	144	view →
COAD	DFS	Tertile	II,III,IV	0.111	0.756	<.001	54	view →
LAML	DFS	Tertile	All	0.111	0.571	.018	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.374	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR3914-1–BLCA (OS)

Open the BLCA breakdown →